1) Antiresorptives
骨转换抑制剂
2) ACEI
转换酶抑制剂
1.
Clinical observation of the effect of ACEI and spironolactone together on CHF;
伍用转换酶抑制剂及螺内酯治疗充血性心力衰竭的临床观察
2.
2004,a total of 126 patients with ACS and AF were divided into two groups:ACEI treatment group(82),and control group(44).
目的:探讨转换酶抑制剂(ACEI)卡托普利在急性冠脉综合征(ACS)合并心房颤动(房颤)治疗中的作用。
4) ACEI
血管转换酶抑制剂
1.
Effects of the combination of low molecular weight heparin and ACEI on albuminuria in diabetic nephropathy;
低分子肝素联合血管转换酶抑制剂对糖尿病肾病显性蛋白尿的治疗观察
5) Angiotensin-converting enzyme inhibitor(ACEI)
血管转换酸抑制剂
6) Bone resorption inhibitor
骨吸收抑制剂
1.
Amino bisphosphonate,as a bone resorption inhibitor,shows very significant effects for a long time in a quite small dosage,the synthetic method was improved by the direct reaction of amino acid with phosphorus trichloride,averting from using anhydrous phosphorous acid,anhydrous reagents and anhydrous solvents.
氨基膦酸作为骨吸收抑制剂 ,疗效显著、剂量小、作用时间长 。
补充资料：血管紧张素转换酶抑制剂
血管紧张素转换酶抑制剂
converting enzyme inhibitor of angiotensin
能够抑制血管紧张素转换酶的活性、使血管紧张素Ⅰ不能转换成血管紧张素Ⅱ的物质，如替普罗肽(又称SQ20881）及卡托普利(又称SQ14225）。用于肾血管性高血压及高血压危象。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条